A Pilot Study of Topical Antiflammin-2 for Psoriasis

Completed

Conditions studied: Psoriasis

In brief

This study is a pilot trial designed to evaluate topical antiflammin-2, a phospholipase A2 (PLA2) inhibitor, in the treatment of chronic plaque psoriasis. Antiflammin-2 in an ointment base, or the vehicle alone will each be applied four times per day to a single plaque in a randomized, double-blinded fashion.

Key facts

Study ID
NCT00001371
Run by
National Cancer Institute (NCI)
People needed
24
Starts
1993-12-01
Expected to finish
2000-12-01
Last updated by the study team
2008-03-04

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.